Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells.
Int J Cancer
; 144(6): 1356-1366, 2019 03 15.
Article
in En
| MEDLINE
| ID: mdl-30125350
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Drug Resistance, Neoplasm
/
Clonal Evolution
/
Kidney Neoplasms
/
Antineoplastic Agents
Limits:
Adult
/
Aged
/
Animals
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Cancer
Year:
2019
Type:
Article
Affiliation country:
Finland